Lineage Cell Therapeutics stock rises on positive 36-month OpRegen data By Investing.com Lineage Cell Therapeutics stock rises on positive 36-month OpRegen data…
Broadwood Partners acquires $6 million in Lineage Cell Therapeutics shares By Investing.com Broadwood Partners acquires $6 million in Lineage Cell Therapeutics shares…
Earnings call: Lineage Cell Therapeutics reports on clinical programs By Investing.com Earnings call: Lineage Cell Therapeutics reports on clinical programs…